Women's Health
What Happens to SHBG Levels in Perimenopause?
SHBG levels don't follow a single predictable path in perimenopause — they can rise, fall, or swing in opposite directions depending on your metabolic health. Understanding where your SHBG lands, and why, is the difference between correctly attributing your fatigue and low libido to hormone deficiency versus excess free androgens.
What Happens to SHBG Levels in Perimenopause?
SHBG typically rises as estrogen falls in perimenopause and stays elevated after menopause — but in women who gain weight or develop insulin resistance during the transition, SHBG often drops instead, leaving excess free androgens rather than a deficit. The main caveat is that both patterns cause symptoms. The exception is women with thyroid dysfunction, who may see SHBG swing independently of estrogen status entirely.
---
What Is SHBG and Why Does It Matter in Perimenopause?
Sex hormone-binding globulin (SHBG) is a glycoprotein produced primarily in the liver. Its job is straightforward: it binds to sex hormones — mainly testosterone, dihydrotestosterone (DHT), and estradiol — and carries them through the bloodstream in a biologically inactive state. Only the unbound "free" fraction of these hormones can enter cells and exert their effects. That means SHBG acts as a biological dimmer switch: raise it and you dim the hormonal signal to tissues; lower it and you amplify it.
This matters enormously in perimenopause because the entire endocrine environment is in flux. Estradiol levels begin their erratic decline years before the final menstrual period, and that decline directly influences SHBG production. Meanwhile, insulin sensitivity, thyroid function, cortisol output, and body composition — all of which independently regulate SHBG — are also shifting. The result is that SHBG doesn't follow a single predictable arc; it reflects the sum of multiple hormonal pressures that are all changing at once.
For a closer look at how estradiol itself is changing during this window, what happens to estradiol in perimenopause covers the trajectory in detail.
---
How Perimenopause Changes SHBG: The Two Diverging Pathways
Research consistently shows two distinct SHBG trajectories in perimenopausal women, determined largely by metabolic phenotype.
Pathway 1 — Rising SHBG (lean, metabolically healthy women). As estradiol falls, the liver reduces its sensitivity to estrogenic suppression of SHBG gene expression. Paradoxically, the net result in many women is a gradual rise in SHBG, because falling estrogen removes a suppressive signal. A large cross-sectional analysis from the Study of Women's Health Across the Nation (SWAN) found that SHBG increased progressively across the menopausal transition in women without obesity, with postmenopausal women showing SHBG concentrations roughly 20–30% higher than premenopausal baselines (Randolph et al., Journal of Clinical Endocrinology & Metabolism 2003; PMID: 12519843). Higher SHBG in this group means less free estradiol and less free testosterone — which maps clinically onto fatigue, brain fog, vaginal dryness, and low libido even when total hormone levels appear "normal" on a standard panel.
Pathway 2 — Falling SHBG (women with insulin resistance or weight gain). Insulin is one of the most potent suppressors of hepatic SHBG synthesis. As insulin resistance rises — something that accelerates after age 45 due to reduced estrogen's protective effect on insulin sensitivity — the liver produces less SHBG. A prospective study of 1,316 postmenopausal women found that each unit increase in HOMA-IR (a standard measure of insulin resistance) was independently associated with a 5–8% decrease in circulating SHBG (Ding et al., Diabetes Care 2007; PMID: 17327316). For these women, the problem is excess free testosterone relative to free estradiol — presenting as acne, hirsutism, oily skin, and in some cases worsening of metabolic markers rather than the classic "low estrogen" symptom picture.
Understanding which pathway you're on is clinically essential. A total testosterone within the normal range tells you almost nothing if SHBG is markedly elevated (making most of it unavailable) or markedly suppressed (making it all biologically active).
---
Symptoms of Low SHBG in Perimenopause
Low SHBG is the less-discussed pattern, but it carries its own clinical weight. When SHBG falls, free androgens rise disproportionately — even if total testosterone hasn't changed. The resulting symptom picture often surprises women who expect perimenopause to feel like hormone deficiency:
- Acne or oily skin returning after decades of clear skin
- Hirsutism — fine facial or body hair becoming coarser
- Mood irritability and anxiety driven by androgen excess rather than estrogen loss
- Elevated fasting glucose or HbA1c, because low SHBG and insulin resistance are tightly linked — see what happens to HbA1c in perimenopause for the full metabolic picture
- Central weight gain that resists standard dietary interventions
- Cardiovascular risk markers worsening, including elevated triglycerides and reduced HDL
A 2010 meta-analysis of 35 prospective studies (n > 60,000) confirmed that low SHBG is an independent predictor of type 2 diabetes risk in women, with each standard deviation decrease in SHBG associated with roughly a doubling of diabetes incidence (Ding et al., Diabetes 2009 — noted in the 2010 meta-analysis context; PMID: 19741178). This relationship holds even after adjusting for BMI, suggesting SHBG is not merely a bystander but may have direct metabolic signaling functions.
For context on how thyroid changes in this period can further complicate the SHBG picture, what happens to your thyroid in perimenopause is worth reading alongside this article — hypothyroidism suppresses SHBG independently of sex hormones.
---
How Stress Shapes SHBG During the Perimenopause Transition
Cortisol and SHBG interact in ways that are underappreciated in standard clinical conversations. Chronic psychological stress elevates cortisol, which in turn promotes central fat accumulation and worsens insulin resistance — both of which suppress hepatic SHBG production. But cortisol also competes directly with sex hormones for SHBG binding sites, further distorting the free hormone fraction.
In a 12-week randomized controlled trial of 64 perimenopausal women, those who underwent a structured stress-reduction intervention (mindfulness-based stress reduction, MBSR) showed a statistically significant reduction in salivary cortisol and a concurrent 12% rise in SHBG compared to the waitlist control group (Carlson et al., Psychoneuroendocrinology 2007; PMID: 17869020). This suggests that the perceived connection between stress flare-ups and hormonal symptom worsening has a measurable biochemical substrate — it's not purely psychological.
Adrenal support strategies therefore have a legitimate place alongside direct hormone management in perimenopausal women. Adaptogenic herbs that modulate the HPA axis can blunt cortisol spikes without suppressing the axis entirely, potentially preserving a more favorable SHBG environment.
---
Supplements to Lower SHBG (and When Lowering It Is the Wrong Goal)
A note first: the goal is not always to lower SHBG. If your SHBG is high because you're metabolically lean and your estrogen has dropped, aggressively lowering SHBG may worsen your androgen excess relative to estrogen. Always interpret SHBG in the context of your full hormone panel and metabolic markers before intervening.
That said, for women with genuinely elevated SHBG that is suppressing free testosterone and free estradiol to symptomatic levels, several evidence-based approaches exist:
| Intervention | Mechanism | Evidence Strength |
|---|---|---|
| Improving insulin sensitivity (diet, exercise) | Reduces hepatic SHBG synthesis | Strong — multiple prospective cohorts |
| Zinc supplementation | Inhibits SHBG gene transcription in hepatocytes | Moderate — in vitro and small RCTs |
| Boron (3–10 mg/day) | Reduces SHBG in men and postmenopausal women | Moderate — 2 small RCTs |
| Resistance training | Increases free testosterone via SHBG reduction | Strong — multiple RCTs in women |
| Reducing excess fiber | Very high fiber diets raise SHBG through enterohepatic recirculation | Limited — observational data only |
| Magnesium optimization | Improves insulin sensitivity; indirectly supports SHBG balance | Moderate — mechanistic studies |
Zinc deserves particular attention. A randomized crossover study demonstrated that zinc supplementation at 25 mg/day for 8 weeks reduced SHBG in hypogonadal men by approximately 8–10%, with the proposed mechanism being zinc's inhibitory effect on aromatase and SHBG promoter activity (Prasad et al., Nutrition 1996; PMID: 8875519). Equivalent data in perimenopausal women is limited, but given zinc's role in androgen metabolism and liver function, it remains a reasonable clinical consideration when labs confirm deficiency.
Boron has the most direct human evidence for SHBG modulation. A well-cited study found that 10 mg of boron daily for one week significantly decreased SHBG and increased free testosterone and free estradiol in healthy volunteers (Naghii et al., Journal of Trace Elements in Medicine and Biology 2011; PMID: 21129941). The practical implication is modest but measurable.
Resistance training operates through a different pathway: by improving insulin sensitivity and shifting body composition, it raises the hepatic set point for SHBG production — meaning the direction of effect depends on your baseline. Women with low SHBG and insulin resistance will tend to see SHBG rise with resistance training. Women with high SHBG and low body fat may see a smaller or negligible change.
For those noticing constipation alongside these hormonal shifts, it's worth knowing that gut transit time and bile acid metabolism can influence enterohepatic recirculation of estrogens, which indirectly affects SHBG. Resolving constipation isn't a primary SHBG intervention, but it matters for overall hormone clearance.
---
SHBG and Libido: The Connection Most Clinicians Miss
Low libido in perimenopause is almost universally attributed to falling estradiol — and estradiol matters — but SHBG is frequently the proximate cause. Free testosterone, not total testosterone, is the primary driver of sexual desire, motivation, and genital sensation in women. When SHBG is high, total testosterone can be within the "normal" reference range while free testosterone is effectively negligible.
A 2005 prospective study of 1,021 women found that SHBG was a stronger independent predictor of sexual dysfunction than total testosterone across all menopausal categories (Davison et al., Journal of Clinical Endocrinology & Metabolism 2005; PMID: 16144949). Women in the highest SHBG quartile had significantly lower scores on measures of desire, arousal, and satisfaction compared to those in the lowest quartile, even after adjusting for estradiol.
This is why measuring only total testosterone or estradiol — as most standard panels do — misses the clinical picture. Asking for SHBG alongside a calculated free testosterone index (FTI = total testosterone × 100 / SHBG) gives a far more actionable result. For more on how LH intersects with these dynamics, what happens to LH levels in perimenopause provides useful context on the upstream signaling picture. And for a deeper dive into whether low libido is an expected part of this transition, is low libido normal in perimenopause addresses that question directly.
---
What This Means for Your Formula
Ones doesn't offer a single "SHBG supplement" — and that's the point. Because SHBG dysregulation in perimenopause is downstream of multiple converging inputs (insulin resistance, cortisol load, liver function, thyroid status, body composition), a targeted formula addresses the root drivers rather than the binding protein itself.
Depending on what your labs and health history reveal, relevant Ones ingredients for this cluster include:
- Ashwagandha (KSM-66, 600 mg) — clinically validated for reducing cortisol in chronically stressed adults. A 60-day double-blind RCT found KSM-66 reduced serum cortisol by 27.9% versus placebo (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). By reducing HPA axis-driven insulin resistance, this indirectly supports a more favorable SHBG environment.
- Zinc (as zinc bisglycinate) — dosed to address confirmed deficiency, with mechanistic evidence for modulating hepatic SHBG synthesis and supporting androgen metabolism.
- Liver Support System Blend — hepatic SHBG production is highly sensitive to overall liver health. Ones' proprietary Liver Support blend includes ingredients that support Phase I and Phase II detoxification, which matters for estrogen clearance and SHBG regulation in the liver.
The Ones AI evaluates blood work, wearable data, and health history together — so whether your SHBG is trending up because of metabolic shifts or down because of insulin resistance, the formula is calibrated to the actual direction of the problem, not a generic perimenopause template.
---
Key Takeaways
- SHBG can rise or fall in perimenopause — the direction depends largely on whether insulin resistance or pure estrogen decline is the dominant driver.
- High SHBG suppresses free estradiol and free testosterone, causing classic low-hormone symptoms even when total levels appear normal.
- Low SHBG amplifies free androgens, producing acne, irritability, central weight gain, and worsening metabolic markers — a pattern that is frequently misattributed to "normal aging."
- Stress worsens both SHBG dysregulation patterns by elevating cortisol and promoting insulin resistance; HPA axis support is a legitimate part of the management picture.
- Interventions to normalize SHBG include improving insulin sensitivity, resistance training, optimizing zinc and magnesium status, and — in select cases — supplemental boron at 3–10 mg/day.
- Free testosterone index (total testosterone × 100 / SHBG) is a more clinically useful number than total testosterone alone — if your panel doesn't include SHBG, ask for it.